Outcome of 177Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome of 177Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters

Published:2022-05-11 Issue:8 Volume:47 Page:e521-e528
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Has Simsek Duygu,Kuyumcu Serkan,Karadogan Seyfullah,Ozkan Zeynep Gozde,Isik Emine Goknur,Basaran Mert,Sanli Mehmet Oner,Sanli Yasemin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference37 articles.

1. Cancer statistics, 2020;CA Cancer J Clin,2020

2. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients;Hum Pathol,2000

3. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion;Nat Clin Pract Urol,2009

4. Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis;Prostate Cancer Prostatic Dis,2014

5. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer;Eur Urol,2021

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of Optimum Imaging Numbers for <sup>177</sup>Lu-PSMA Radionuclide Treatment Dosimetric Calculation;Istanbul Medical Journal;2024-05-24

2. Favorable Response of 225Ac-PSMA in the Treatment of Castration-Resistant Prostate Cancer With High Bone Metastasis Burden;Clinical Nuclear Medicine;2024-04-05

3. 177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers;Cancer Treatment Reviews;2024-04

4. 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer;Clinical Nuclear Medicine;2023-12-28

5. Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?;Translational Cancer Research;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3